1094 related articles for article (PubMed ID: 20872224)
1. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
3. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
4. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
Kelly T
Drug Resist Updat; 2005; 8(1-2):51-8. PubMed ID: 15939342
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: Implications for melanoma invasion.
Wäster P; Rosdahl I; Gilmore BF; Seifert O
Int J Oncol; 2011 Jul; 39(1):193-202. PubMed ID: 21491083
[TBL] [Abstract][Full Text] [Related]
7. Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2.
Yeh FL; Shen HD; Lin MW; Chang CY; Tai HY; Huang MH
Burns; 2006 May; 32(3):299-304. PubMed ID: 16487663
[TBL] [Abstract][Full Text] [Related]
8. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Ospelt C; Mertens JC; Jüngel A; Brentano F; Maciejewska-Rodriguez H; Huber LC; Hemmatazad H; Wüest T; Knuth A; Gay RE; Michel BA; Gay S; Renner C; Bauer S
Arthritis Rheum; 2010 May; 62(5):1224-35. PubMed ID: 20155839
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
Ong CT; Khoo YT; Tan EK; Mukhopadhyay A; Do DV; Han HC; Lim IJ; Phan TT
J Pathol; 2007 Jan; 211(1):95-108. PubMed ID: 17136757
[TBL] [Abstract][Full Text] [Related]
11. DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.
Makino S; Mitsutake N; Nakashima M; Saenko VA; Ohtsuru A; Umezawa K; Tanaka K; Hirano A; Yamashita S
J Dermatol Sci; 2008 Sep; 51(3):171-80. PubMed ID: 18406579
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Do DV; Ong CT; Khoo YT; Carbone A; Lim CP; Wang S; Mukhopadhyay A; Cao X; Cho DH; Wei XQ; Bellone G; Lim I; Phan TT
Br J Dermatol; 2012 Jun; 166(6):1275-88. PubMed ID: 22050194
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
14. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
15. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
[TBL] [Abstract][Full Text] [Related]
17. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
18. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
Carroll LA; Koch RJ
Med Sci Monit; 2003 Mar; 9(3):BR97-108. PubMed ID: 12640331
[TBL] [Abstract][Full Text] [Related]
19. Elevated interleukin-6 expression in keloid fibroblasts.
Xue H; McCauley RL; Zhang W
J Surg Res; 2000 Mar; 89(1):74-7. PubMed ID: 10720455
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
